IQVIA Gets CDSCO Panel Nod to Study Antipsychotic drug Lumateperone Dr. Divya Colin17 Nov 2024 5:45 PM ISTNew Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Transcranial magnetic stimulation Found Effective in Reducing Auditory Hallucinations in Schizophrenia: Study Dr Riya Dave12 Nov 2024 8:15 PM ISTResearchers have found that repetitive transcranial magnetic stimulation (rTMS) can efficiently reduce the symptoms of auditory verbal hallucination...
Boehringer Ingelheim, Broad Institute of MIT and Harvard to develop treatments for people with mental health conditions Ruchika Sharma8 Nov 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have agreed...
IQVIA Gets CDSCO Panel Nod to Study KarXT in Schizophrenia Dr. Divya Colin31 Oct 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to IQVIA...
Medical Bulletin 24/ October/ 2024 Dr. Bhumika Maikhuri24 Oct 2024 3:00 PM ISTHere are the top health news for the day:Need to Remove Existing Barriers for Effective Weight Loss? Expanding access to new, highly effective...
Schizophrenia Linked to Fourfold Increase in Sudden Cardiac Death Risk: Study Finds Dr. Bhumika Maikhuri24 Oct 2024 8:45 AM ISTThe lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease—known as sudden cardiac...
Lifetime sudden cardiac death risk more than four times higher for those with schizophrenia: Study Dr. Kamal Kant Kohli24 Oct 2024 8:00 AM ISTThe lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease-known as sudden cardiac...
Zydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg MD Bureau Team12 Oct 2024 12:00 PM ISTAhmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the...
Obstetric Complications linked to Severe Psychopathology in Schizophrenia Spectrum Disorders, suggests study Medha Baranwal11 Oct 2024 8:00 PM ISTSpain: A recent study published in Neuroscience & Biobehavioral Reviews has revealed that patients with schizophrenia and related disorders who...
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults Ruchika Sharma29 Sept 2024 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...
Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release Ruchika Sharma27 Sept 2024 4:40 PM ISTMumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Cognitive Decline Increases Risk of Natural Cause Mortality in Schizophrenia, New Study Reveals Medha Baranwal23 Sept 2024 8:00 PM ISTUSA: A recent prospective cohort study published in JAMA Network Open has identified lower cognitive functioning as a significant risk factor for...
